Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 50 of the 54 references it cites were found in a registry or an index.

A systematic review and meta-analysis on the regulation of programmed cell death-1 on T-cells in type 2 diabetes

Open access

Abstract

Background: To assess T-cell exhaustion mediated by programmed cell death 1 (PD-1) pathway in patients living with type 2 diabetes (T2D). Methods: MEDLINE and ProQuest electronic databases were searched for eligible studies from inception up to February 2020. The risk of bias and the quality of evidence were independently assessed by two reviewers using the modified Newcastle-Ottawa Scale adapted for cross-sectional studies and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool, respectively. The random effects model was used to calculate effect estimates. Results: We identified 5 studies involving 380 participants which met the inclusion criteria. The pooled estimates showed elevated T helper cell exhaustion in patients with T2D in comparison to controls (mean difference [MD]: 2.57% [95% confidence interval [CI]: –3.84, 8.97]; I 2 = 100%, P < .00001). Likewise, T2D patients had increased levels of cytotoxic T-cells exhaustion (MD: 3.09% [95% CI: –12.96, 19.14]; I 2 = 100%, P < .00001). Although the upregulation of PD-1 on T-cells did not affect glucose metabolism-related profiles, it was associated with inflammation and the development of cardiovascular disease. Conclusion: In patients living with T2D, immune dysfunction is at least in part due to T-cell exhaustion mediated by the upregulation of PD-1 expression. Therefore, the use of immune checkpoint inhibitors as a therapeutic strategy may be beneficial in restoring immune function in patients with T2D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000025488

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 PRISMA diagram showing the study selection process. PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analysis.
Figure 1 PRISMA diagram showing the study selection process. PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analysis.CC BY-NC · PubMed Central
Figure 2 A comparison of mean difference of programmed cell death 1 (PD-1) expression on T helper cells (A) and cytotoxic T-cells (B) between patients with T2D and healthy controls. T2D = type 2 diabetes.
Figure 2 A comparison of mean difference of programmed cell death 1 (PD-1) expression on T helper cells (A) and cytotoxic T-cells (B) between patients with T2D and healthy controls. T2D = type 2 diabetes.CC BY-NC · PubMed Central
Figure 3 An overview of mechanisms that implicates programmed cell death-1 signaling and its modulatory effects on T-cell function. In brief, chronic immune activation in type 2 diabetes mellitus is known to increase cardiovascular risk and T-cell exhaustion, which is likely to be mediated by the upregulation of programmed cell death-1 (PD-1), a negative T-cell regulator. Thus, increased expression of PD-1 can alter glucose metabolism by inhibiting the actions of phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling. It further appears that PD-1 expression promotes T-cell proliferation and survival but inhibit their effector functions by upregulating the detrimental mechanisms such Janus kinase/signal transducers and activators of transcription (JAK/STAT) and nuclear factor kappa B (NF-κB) signaling pathways.
Figure 3 An overview of mechanisms that implicates programmed cell death-1 signaling and its modulatory effects on T-cell function. In brief, chronic immune activation in type 2 diabetes mellitus is known to increase cardiovascular risk and T-cell exhaustion, which is likely to be mediated by the upregulation of programmed cell death-1 (PD-1), a negative T-cell regulator. Thus, increased expression of PD-1 can alter glucose metabolism by inhibiting the actions of phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling. It further appears that PD-1 expression promotes T-cell proliferation and survival but inhibit their effector functions by upregulating the detrimental mechanisms such Janus kinase/signal transducers and activators of transcription (JAK/STAT) and nuclear factor kappa B (NF-κB) signaling pathways.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 6

Metadata

Authors
Nyambuya, T. M., Dludla, P. V., Mxinwa, V., & Nkambule, B. B.
Affiliations
  • Namibia University of Science and Technology (NA)
  • South African Medical Research Council (ZA)
  • University of KwaZulu-Natal (ZA)
Corresponding author
Nyambuya, Tawanda Maurice
Venue
Medicine
Published
2021-04-16
Volume
100
Issue
15
Pages
e25488
ISSN
  • 0025-7974 (ISSN-L)
  • 1536-5964
OpenAlex
W3153913656
Cited by
6
References
54
Citations by year
2026: 1 · 2025: 2 · 2023: 1 · 2022: 2
FWCI
0.08
Type
journal article
Language
en
Open access
Locations
  • Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Fogarty International Center (D43TW010131)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
type 2 diabetes, PD-1, PDCD1, T cell exhaustion, T helper cells, cytotoxic T lymphocytes, immune dysfunction, inflammation, cardiovascular disease, immune checkpoint inhibitors, glucose metabolism
MeSH terms
Adult, Aged, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Humans, Immunity, Cellular, Male, Middle Aged, T-Lymphocytes, Signal Transduction, Up-Regulation, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A systematic review and meta-analysis on the regulation of programmed cell death-1 on T-cells in type 2 diabetes. https://app.cochat.ai/papers/10.1097/md.0000000000025488
The paper
Nyambuya, T. M., Dludla, P. V., Mxinwa, V., & Nkambule, B. B. (2021). A systematic review and meta-analysis on the regulation of programmed cell death-1 on T-cells in type 2 diabetes. Medicine. https://doi.org/10.1097/md.0000000000025488

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.